The Application Notebook
Phenol formaldehyde resins (PFR) are used in various industrial products because of their versatile properties. Thermoplastic and thermo-reactive resin types differ in the degree of remaining reactive groups and their molar mass distribution (MMD). We compared the MMDs of two phenolic resins by gel permeation chromatography (GPC).
Phenol formaldehyde resins (PFR) are used in various industrial products because of their versatile properties. Thermoplastic and thermo-reactive resin types differ in the degree of remaining reactive groups and their molar mass distribution (MMD). We compared the MMDs of two phenolic resins by gel permeation chromatography (GPC).
Phenol formaldehyde resins are condensation polymers. They are obtained by condensing phenol with formaldehyde in the presence of an acidic or alkaline catalyst. Depending on the synthesis conditions (comonomer ratio, pH), thermoplastic novolac and thermo-reactive resol types can be formed. The development of molar mass distributions in a thermo-reactive (PFR 1) and a thermoplastic (PFR 2) resin can be analyzed by GPC.
Experimental Conditions
Analysis was performed on an EcoSEC GPC System with refractive index (RI) detector using a bank of two semi-micro GPC columns (6.0 mm × 150 mm, 3 μm) with different exclusion limits. MMDs were determined for each sample using a calibration curve that was created at the same experimental conditions with Tosoh polystyrene standards. Calibration curve data were fitted with a cubic function and error values were less than 5%.
Columns: 1 × TSKgel SuperH2500 + 1 × TSKgel SuperH2000 (6.0 × 150 mm, 3 μm)
Mobile phase: THF
Flow rate: 0.35 mL/min
Temperature: 40 °C
Sample: PFR 1, PFR 2 (5.0 mg/mL THF)
Injection volume: 30 μL
Detection: Refractive index
Results
Figure 1 shows GPC elution curves for the two PFR samples. Molecules of PFR 1 start eluting later than those of PFR 2. The use of two semi-micro TSKgel columns in series with different exclusion limits delivered the best resolution for different molar mass distributions within each sample even at the very low molar mass range.
The GPC chromatograms show multiple MMDs for both resins. Based on the polystyrene calibration curve, MMDs were calculated (Figure 2). PFR 1 shows a lower molar mass distribution than PFR 2.
Conclusion
The MMDs of two PFR resins were determined via a dual flow RI detector using the EcoSEC GPC system and semi-micro GPC columns. The GPC analysis shows that the resol type PFR 1 resins have low MMDs compared to the thermoplastic PFR 2 resin. Highly resolved multiple MMDs were observed for both resins. This study shows that GPC is a powerful tool to study the molar mass variations of PFR resins. In addition, the semi-micro design of the EcoSEC GPC system allows the use of semi-micro columns, resulting in reduced solvent consumption and analysis time compared to conventional GPC analysis.
Tosoh Bioscience GmbH
Im Leuschnerpark 4 64347 Griesheim, Darmstadt, Germany
Tel: +49 6155 7043700 Fax: +49 6155 8357900
E-mail:info.tbg@tosoh.comWebsite:www.tosohbioscience.de
Free Poster: NDSRI Risk Assessment and Trace-Level Analysis of N-Nitrosamines
April 25th 2025With increasing concern over genotoxic nitrosamine contaminants, regulatory bodies like the FDA and EMA have introduced strict guidelines following several high-profile drug recalls. This poster showcases a case study where LGC and Waters developed a UPLC/MS/MS method for quantifying trace levels of N-nitroso-sertraline in sertraline using Waters mass spectrometry and LGC reference standards.
New TRC Facility Accelerates Innovation and Delivery
April 25th 2025We’ve expanded our capabilities with a state-of-the-art, 200,000 sq ft TRC facility in Toronto, completed in 2024 and staffed by over 100 PhD- and MSc-level scientists. This investment enables the development of more innovative compounds, a broader catalogue and custom offering, and streamlined operations for faster delivery. • Our extensive range of over 100,000 high-quality research chemicals—including APIs, metabolites, and impurities in both native and stable isotope-labelled forms—provides essential tools for uncovering molecular disease mechanisms and exploring new opportunities for therapeutic intervention.
New Guide: Characterising Impurity Standards – What Defines “Good Enough?”
April 25th 2025Impurity reference standards (IRSs) are essential for accurately identifying and quantifying impurities in pharmaceutical development and manufacturing. Yet, with limited regulatory guidance on how much characterisation is truly required for different applications, selecting the right standard can be challenging. To help, LGC has developed a new interactive multimedia guide, packed with expert insights to support your decision-making and give you greater confidence when choosing the right IRS for your specific needs.
Using the Carcinogenic Potency Categorisation Approach (CPCA) to Classify N-nitrosamine Impurities
April 25th 2025Learn how to manage nitrosamine impurities in pharmaceuticals with our free infographic. Discover how the CPCA approach establishes acceptable intake limits and guides the selection of NDSRI reference samples. Stay compliant and ensure safety with our ISO-accredited standards.